Detalhe da pesquisa
1.
High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma.
Leuk Res
; 31(8): 1063-8, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17324463
2.
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation.
Bone Marrow Transplant
; 36(5): 437-41, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15980879